C23H23FN2O9
Neat
490.44
2OTX3QC8IB; Cabozantinib metabolite M5; Dequinolinyl cabozantinib glucuronide; UNII-2OTX3QC8IB; 1628530-43-7; 4-(((1-(((4-Fluorophenyl)amino)carbonyl)cyclopropyl)carbonyl)amino)phenyl beta-D-glucopyranosiduronic acid; beta-D-Glucopyranosiduronic acid, 4-(((1-(((4-fluorophenyl)amino)carbonyl)cyclopropyl)carbonyl)amino)phenyl; .BETA.-D-GLUCOPYRANOSIDURONIC ACID and 4-(((1-(((4-FLUOROPHENYL)AMINO)CARBONYL)CYCLOPROPYL)CARBONYL)AMINO)PHENYL; 4-(((1-(((4-FLUOROPHENYL)AMINO)CARBONYL)CYCLOPROPYL)CARBONYL)AMINO)PHENYL .BETA.-D-GLUCOPYRANOSIDURONIC ACID
(2S, 3S, 4S, 5R, 6S)-6-[4-[[1-[(4-fluorophenyl)carbamoyl]cyclopropanecarbonyl]amino]phenoxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C23H23FN2O9/c24-11-1-3-12(4-2-11)25-21(32)23(9-10-23)22(33)26-13-5-7-14(8-6-13)34-20-17(29)15(27)16(28)18(35-20)19(30)31/h1-8,15-18,20,27-29H,9-10H2,(H,25,32)(H,26,33)(H,30,31)/t15-,16-,17+,18-,20+/m0/s1